Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Hoffmann la Roche Inc
Hoffmann la Roche Inc_20131212
  

Hoffmann la Roche Inc patents

Recent patent applications related to Hoffmann la Roche Inc. Hoffmann la Roche Inc is listed as an Agent/Assignee. Note: Hoffmann la Roche Inc may have other listings under different names/spellings. We're not affiliated with Hoffmann la Roche Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | Hoffmann la Roche Inc-related inventors




Date Hoffmann la Roche Inc patents (updated weekly) - BOOKMARK this page
08/17/17 new patent  Peptide macrocycles against acinetobacter baumannii
08/17/17 new patent  Antibodies binding to human and cynomolgus cd3 epsilon
08/17/17 new patent  Her3/her2 bispecific antibodies binding to the beta-hairpin of her3 and domain ii of her2
08/17/17 new patent  Genetic markers for predicting responsiveness to therapy with hdl-raising or hdl mimicking agent
08/10/17Dihydroquinoline pyrazolyl compounds
08/10/17Dihydroquinoline pyrazolyl compounds
08/10/172,2,2-trifluoroethyl-thiadiazines
08/10/17Pyridinyloxy- and phenyloxy-pyrazolyl compounds
08/10/17New dihydroquinoline pyrazolyl compounds
08/10/17Thiol-based deep eutectic solvent
08/10/17Methods for personalizing patient cancer therapy with an mdm2 antagonist
08/10/17In vitro prediction of in vivo half-life
08/03/17Formulations
08/03/17Ethynyl derivatives
08/03/17Novel compounds for the treatment of infectious diseases
07/27/17Treatment method
07/27/17Rapid cloning and expression of cognate antibody variable region gene segments
07/27/17Method for selecting antibodies with modified fcrn interaction
07/27/17Dosing a fluid at a volume of less than one milliliter
07/27/17Method for determining whether reconstitution of a solution in a container is completed
07/27/17Velocity factor
07/20/17Novel triazolo[4,5-d]pyrimidines
07/20/17Spirodiamine derivatives as aldosterone synthase inhibitors
07/20/17Vh-vl-interdomain angle based antibody humanization
07/13/17Compounds for treating spinal muscular atrophy
07/13/17Compounds for treating spinal muscular atrophy
07/06/17Bispecific t cell activating antigen binding molecules
07/06/17Oligonucleotides for inducing paternal ube3a expression
07/06/17Method for monitoring cathepsin s inhibition
06/29/17Inhibitors of bruton's tyrosine kinase
06/29/17Method for the purification of antibodies
06/22/17Mglu2/3 antagonists for the treatment of autistic disorders
06/22/17Processes for the preparation of oxytocin analogues
06/22/17Bispecific t cell activating antigen binding molecules
06/22/17Method and system for preparing synthetic multicomponent biotechnological and chemical process samples
06/15/17Radiolabeled cannabinoid receptor 2 ligand
06/15/17Protein expression from multiple nucleic acids
06/08/17Novel pyridazones and triazinones for treatment and prophylaxis of hepatitis b virus infection
06/08/17Separation apparatus and use thereof
06/01/17Method for increasing the specific production rate of eukaryotic cells
05/25/17Substituted azetidine derivatives
05/25/17Substituted pyrazino[2,2-a]isoquinoline derivatives
05/25/17Tetravalent multispecific antibodies
05/18/176-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
05/18/172-oxa-5-azabicyclo[2.2.1]heptan-3-yl derivatives
05/18/17Immunoglobulin purification
05/11/17Blood brain barrier shuttle
05/11/172-phenylimidazo[1,2-a]pyrimidines as imaging agents
05/11/17Humanized anti-tau(ps422) antibodies and methods of use
05/11/17Multispecific antibodies
05/11/17Methods for the prediction of a personalized esa-dose in the treatment of anemia
05/04/17Pharmaceutical composition comprising non-ionic surfactants
04/27/17Ethynyl derivatives
04/27/17Anti-alpha-synuclein antibodies and methods of use
04/27/17Bispecific antibodies specific for pd1 and tim3
04/27/17Antibodies against human csf-1r and uses thereof
04/27/17Bispecific antibodies specific for a costimulatory tnf receptor
04/27/17Bispecific t cell activating antigen binding molecules
04/27/17Anti-brdu antibodies and methods of use
04/27/17Method for detecting multispecific antibody light chain mispairing
04/20/17Humanized anti-tau(ps422) antibody brain shuttles and use thereof
04/20/17Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
04/20/17Method for obtaining immunoglobulin encoding nucleic acid
04/13/17Indolin-2-one or pyrrolo-pyridin-2-one derivatives
04/06/17Bispecific t cell activating antigen binding molecules
Patent Packs
04/06/17Bispecific t cell activating antigen binding molecules
03/23/17Antiviral compounds
03/23/17Peptides as oxytocin agonists
03/23/17Peptides as oxytocin agonists
03/23/17Method for the selection of a long-term producing cell using histone acylation as markers
03/09/175-oxa-2-azabicyclo[2.2.2]octan-4-yl and 5-oxa-2-azabicyclo[2.2.1]heptan-4-yl derivatives
03/09/17Isoform enriched antibody preparation and obtaining it
03/09/17Responsiveness to angiogenesis inhibitors
03/09/17Method for production of polypeptides
03/02/17Process for making lysine-glutamic acid dipeptide derivatives
03/02/17Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
03/02/17Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
03/02/17Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
03/02/17Covalently linked polypeptide toxin-antibody conjugates
03/02/17Modulation of cell growth and glycosylation in recombinant glycoprotein production
Patent Packs
02/23/17New bicyclic derivatives
02/23/17Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1
02/23/17Monovalent blood brain barrier shuttle modules
02/23/17Modified pseudomonas exotoxin a
02/16/17Glyt1 inhibitors for use in the treatment of hematological disorders
02/16/17Morpholin-pyridine derivatives
02/16/17Fc-region variants with improved protein a-binding
02/09/17Use of n-(4-tert-butylbenzyl)-3-chloro-n-[2-(4-chloro-3-ethyl-phenyl)-ethyl]-2-fluoro-5-trifluoromethyl-benzamide for the treatment of eye diseases
02/09/17Mglu2/3 antagonists for the treatment of intellectual disabilities
02/09/17Novel pyrazol derivatives
02/09/17Solid forms of a pharmaceutically active compound
02/09/17Fc-region variants with modified fcrn-binding properties
02/09/17Fc-region variants with modified fcrn- and maintained protein a-binding properties
02/09/17G-alpha interacting vesicle associated protein (giv) as a predictive marker in stage ii colorectal cancer
02/02/17Selective inhibitors of undifferentiated cells
02/02/17New diazaspirocycloalkane and azaspirocycloalkane
02/02/17Antibodies against human angiopoietin 2
02/02/17Antibodies against human csf-1r and uses thereof
02/02/17Bispecific her2 antibodies and methods of use
01/26/17Small molecule conjugates for intracellular delivery of biologically active compounds
01/19/17Benzazepine dicarboxamide compounds
01/19/17Use of pegylated igf-1 variants for the treatment of neuromuscular disorders
01/19/17Optimized antibody capturing by mixed mode chromatography
01/19/17Antibodies against human csf-1r and uses thereof
01/12/17Ethynyl derivatives
01/12/17Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
01/12/17Spiro-oxazolones
01/12/17Condensed [1,4] diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
01/12/17Method for purifying pegylated erythropoietin
01/12/17Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structure
Social Network Patent Pack
01/05/17Pharmaceutical composition with improved bioavailability
01/05/17Compounds for the treatment of cancer
01/05/17Spr-based bridging assay format for determining the biological activity of multivalent, multispecific molecules
12/29/16Novel pyridine derivatives
12/29/16Novel pyridine derivatives
12/29/16Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography
12/29/16Humanized anti-tau(ps422) antibodies and methods of use
12/22/16Small molecule based conversion of somatic cells into neural crest cells
12/22/16Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)
12/15/16Ethynyl derivatives
Patent Packs
12/15/16Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
12/08/16Spiro-oxazolones
12/01/16Combination therapy of an anti-cd20 antibody with a bcl-2 inhibitor and a mdm2 inhibitor
11/24/16Antigen binding molecules comprising a trimeric tnf family ligand
11/17/16(hetero)aryl imidazoles/pyrazoles for treatment of neurological disorders
11/17/16Novel process for the recovery of beta acetylfuranoside
11/17/16Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation
11/17/16Identification of patients in need of pd-l1 inhibitor cotherapy
11/10/16Biospecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
11/10/16Flouro-naphthyl derivatives
11/10/16Novel imidazoles for the treatment and prophylaxis of respiratory syncytial virus infection
11/10/16N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders
11/10/16Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine
11/10/16Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection
11/10/16Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
11/10/16Novel 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
11/10/16Tnfa-il-17 bispecific antibodies
11/10/16Improved recombinant polypeptide production methods
11/03/16Inhibitors of bruton's tyrosine kinase
11/03/165-aryl-1-imino-1-oxo-[1,2,4]thiadiazines
11/03/16Multispecific domain exchanged common variable light chain antibodies
11/03/16Method for the recombinant production of a polypeptide in prokaryotic cells
11/03/16Biomarkers and methods for progression prediction for chronic kidney disease
10/27/16Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides
10/27/16Inhibitors of bruton's tyrosine kinase
10/27/16Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
10/20/16Novel combination treatment for acute myeloid leukemia (aml)
10/20/16Inhibitors of bruton's tyrosine kinase
10/20/16Mutant transaminases as well as methods and uses relating thereto
10/13/16Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
Patent Packs
10/13/16Biomarkers for hbv treatment response
10/06/16Cetp modulator for use in the treatement of eye disease
10/06/16Combination therapy for the treatment of ovarian cancer
10/06/16Process for the preparation of chiral 2-aryl morpholines
09/29/16Inhibitors of bruton's tyrosine kinase
09/29/16Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof
09/29/16Method for examining a plurality of cultured cells for the presence of periodic structures of at least one target component contained in the cultured cells
09/22/16Pharmaceutical composition
09/22/16Pyrazine derivatives
09/22/16Method for improving antibody stability
09/15/16Imidazole derivatives
09/15/16Octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl
09/15/16Substituted benzamides
09/15/16Specific detection of rat antibodies in mouse serum
09/08/16Combination therapy
09/08/16Benzazepine dicarboxamide compounds
09/08/16Anti-tim3 antibodies and methods of use
09/01/16Pyrido[4,3-b]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders
09/01/16Single b-cell cultivation method
09/01/163d adcc nk facs assay
Social Network Patent Pack
08/25/162-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
08/25/16Genetic markers for predicting responsiveness to therapy
08/18/16Process to manufacture n-[(3s)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide
08/18/16Novel 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
08/18/16Novel pyrazine compounds for the treatment of infectious diseases
08/18/16Cation and anion exchange chromatography method
08/11/16New phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors
08/11/16Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
08/04/16Combination therapy of antibodies against human csf-1r and tlr9 agonist
08/04/16Diazacarbazole derivatives as tau-pet-ligands
08/04/16Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase
08/04/164-amino-imidazoquinoline compounds
07/28/16Moveable chromatography column separator
07/21/16Indol and indazol derivatives
07/21/16Ethynyl derivatives
07/21/16Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
07/21/16Imidazo[1,2-a]pyridin-7-amine
07/21/16Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators
07/21/16T cell activating bispecific antigen binding molecules
07/21/16Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
Social Network Patent Pack
07/21/16Apparatus for leak detection
07/14/16Cap for a container
07/14/16New process
07/14/16Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
07/14/16Antigen binding molecules comprising a tnf family ligand trimer
07/07/16Pyrrolopyridine or pyrazolopyridine derivatives
07/07/16Novel 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
07/07/16Fc-receptor binding modified asymmetric antibodies and methods of use
06/30/16Indole-carboxamides
06/30/16Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors
06/30/16Method for the production of a glycosylated immunoglobulin
06/23/16Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1
06/23/16Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2h)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
06/16/16Novel triazolo[4,5-d]pyrimidine derivatives
06/16/16Therapeutic fusion protein
06/09/16Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
06/09/16Human fcrn-binding modified antibodies and methods of use
06/09/16Combination therapy of anti-her3 antibodies
06/09/16Trimeric antigen binding molecules
06/09/16Device for use in the detection of binding affinities
06/02/16Fcrn-binding abolished anti-igf-1r antibodies and their use in the treatment of vascular eye diseases
05/26/16Compounds for treating spinal muscular atrophy
05/26/16Method for differentiation of pluripotent stem cells into multi-competent renal precursors
05/19/16Stable intravenous formulation
05/19/16Novel pyridine derivatives
05/19/161,7-naphthyridine derivatives
05/19/16Amino acid sequence presenting fusion polypeptide and its use
05/19/16Device for use in the detection of binding affinities
05/12/16Combination of ro5503781 and capecitabine for cancer therapy
05/12/16Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy
Social Network Patent Pack
05/12/16Ethynyl derivatives
05/12/16Method for the selection of a long-term producing cell
05/05/16Novel 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis b virus infection
05/05/16Novel 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
04/14/16Bace1 inhibitors
04/14/16Optimizing the production of antibodies
04/07/16Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives
03/31/16Synthesis of bace inhibitors
03/24/16Novel tetrazolone derivatives
03/24/16Novel processes for the manufacture of propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl)-amide
03/24/16Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
03/24/16Promoter
03/17/16Combined drug administration of dalcetrapib and orlistat
03/17/16New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
03/17/16New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
03/17/16New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
03/17/16Bispecific t cell activating antigen binding molecules
03/17/16Specific detection of rat antibodies in mouse serum
03/10/16Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
03/10/16Sequence dependent aggregation
03/10/16Fc-receptor binding modified asymmetric antibodies and methods of use
03/03/16New aryl-quinoline derivatives
02/25/16Combination therapy for proliferative disorders
02/25/16Bace1 inhibitors
02/25/16Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
02/25/16Antibodies against human csf-1r and uses thereof
02/18/16Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1
02/18/16Isoquinoline derivatives
02/18/16Pd-catalyzed coupling of pyrazole amides







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Hoffmann la Roche Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Hoffmann la Roche Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';